definiens: ( i ) when referring to, means all sales, revenues ( including revenues generated from sub - licenses in the form of lump SUl11S ), receipts and monies, received by BioAxone or its Affiliates during the term of the Licensed Patents from the use, sale, lease, or other transfer, other than royalties received from Sub - licensees, of one or some Licensed Products and ( ii ) when referring to, means all royalty revenues received by BioAxone or its Affiliates during the term of the Licensed Patents from their Sub - licensees of one or some Licensed Products . type 1 and type 2 shall however exclude : ( a ) all equity compensation received by BioAxone ; ( b ) all revenues from research and development agreements ; ( c ) all grants, credits or financial support of any sort related to ~he research and development ; and ( d ) all revenues from material transfer agreements, provided that such agreements do not include license grants or commercialisation rights with respect to the Licensed Patents